OKYO Pharma Limited Sponsored ADR OKYO

Healthcare — Biotechnology

1.38 0.00 0.00% as of 25 Sep

Market cap: $72.4M
P/E: 0.0×

Follow OKYO

Insider Buys (last 12m)

Insider Buys alert about insiders buying in the last 12 month

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '24	Mar '25	Sep '25	Mar '26
ROE Full definition →	+7 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(20.85)	(19.25)	(13.07)	(9.53)
Capital Expenditures Full definition →		—	(0.01)	—	(0.01)
Other line items
Cash ROIC Full definition →		334.24%	482.28%	(1,319.14%)	(28.90%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		4.77	1.10	7.17	0.43
Capex/Depreciation Full definition →		0.00	(0.87)	0.00	(2.03)
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		—	0.00	—	0.00
Capex to Sales Full definition →		—	0.00	—	0.00

Fold the line items

Columns are period end dates